Figure 1: Temporal representation of patient evolution. MMQ = Quiescent multiple myeloma, MM = Multiple myeloma, MC = Monoclonal component (serum), CR = Complete response, PR = Partial response, SD = Stable disease, VMP = Bortezomib, melphalan, and prednisone, Len-Dex = Lenalidomide with dexamethasone, VBMCP = Vincristine, carmustine, melphalan, cyclophosphamide, and prednisone, VBAD = Vincristine, carmustine, doxorubicin, and dexamethasone, Pom-Dex = Pomalidomide and dexamethasone, BLMF = Belantamab mafodotin